Healthcare provider profile · identity verified

Bruce S Kinney, DO

Family Practice · DALLAS, TX · NPI 1619269099

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	747	229
Amlodipine Besylate	Amlodipine Besylate	544	180
Losartan Potassium	Losartan Potassium	279	88
Lisinopril	Lisinopril	249	76
Rosuvastatin Calcium	Rosuvastatin Calcium	233	81
Hydrochlorothiazide	Hydrochlorothiazide	193	59
Gabapentin	Gabapentin	180	72
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	178	51
Metformin Hcl	Metformin Hcl	178	60
Levothyroxine Sodium	Levothyroxine Sodium	168	52
Carvedilol	Carvedilol	147	49
Albuterol Sulfate Hfa	Albuterol Sulfate	144	58
Tramadol Hcl	Tramadol Hcl	135	39
Jardiance	Empagliflozin	131	38
Metoprolol Succinate	Metoprolol Succinate	127	44
Simvastatin	Simvastatin	123	35
Fluticasone Propionate	Fluticasone Propionate	118	56
Tamsulosin Hcl	Tamsulosin Hcl	114	38
Alendronate Sodium	Alendronate Sodium	99	35
Omeprazole	Omeprazole	94	38
Pantoprazole Sodium	Pantoprazole Sodium	94	32
Furosemide	Furosemide	90	39
Pravastatin Sodium	Pravastatin Sodium	85	28
Acetaminophen-Codeine	Acetaminophen With Codeine	84	39
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	84	26
Allopurinol	Allopurinol	80	30
Trazodone Hcl	Trazodone Hcl	78	34
Prednisone	Prednisone	77	42
Nifedipine Er	Nifedipine	75	28
Diclofenac Sodium	Diclofenac Sodium	73	39
Hydralazine Hcl	Hydralazine Hcl	73	26
Eliquis	Apixaban	70	24
Vitamin D2	Ergocalciferol (Vitamin D2)	69	29
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	68	23
Montelukast Sodium	Montelukast Sodium	65	24
Sertraline Hcl	Sertraline Hcl	65	23
Olmesartan Medoxomil	Olmesartan Medoxomil	64	20
Clopidogrel	Clopidogrel Bisulfate	63	24
Metoprolol Tartrate	Metoprolol Tartrate	63	21
Alprazolam	Alprazolam	59	17
Trulicity	Dulaglutide	58	16
Potassium Chloride	Potassium Chloride	53	21
Duloxetine Hcl	Duloxetine Hcl	52	22
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	52	14
Baclofen	Baclofen	50	21
Clonidine Hcl	Clonidine Hcl	50	17
Ozempic	Semaglutide	50	15
Finasteride	Finasteride	42	11
Glipizide	Glipizide	41	12
Pregabalin	Pregabalin	37	13
Triamcinolone Acetonide	Triamcinolone Acetonide	37	25
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	36	suppressed
Famotidine	Famotidine	35	15
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	32	13
Symbicort	Budesonide/Formoterol Fumarate	32	11
Levemir Flexpen	Insulin Detemir	31	11
Tizanidine Hcl	Tizanidine Hcl	31	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	31	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	30	28
Linzess	Linaclotide	30	12
Valsartan	Valsartan	30	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	29	26
Atenolol	Atenolol	28	suppressed
Ondansetron Odt	Ondansetron	27	18
Glimepiride	Glimepiride	26	suppressed
Januvia	Sitagliptin Phosphate	26	12
Paxlovid	Nirmatrelvir/Ritonavir	26	23
Diazepam	Diazepam	25	suppressed
Metformin Hcl Er	Metformin Hcl	25	suppressed
Citalopram Hbr	Citalopram Hydrobromide	24	suppressed
Clonazepam	Clonazepam	24	suppressed
Valacyclovir	Valacyclovir Hcl	24	suppressed
Azithromycin	Azithromycin	23	17
Lactulose	Lactulose	23	suppressed
Meloxicam	Meloxicam	23	13
Methocarbamol	Methocarbamol	23	suppressed
Nitroglycerin	Nitroglycerin	23	11
Spiriva Handihaler	Tiotropium Bromide	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	11
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Fluconazole	Fluconazole	21	13
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Naproxen	Naproxen	21	13
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Spironolactone	Spironolactone	19	suppressed
Meclizine Hcl	Meclizine Hcl	18	suppressed
Tresiba Flextouch U-100	Insulin Degludec	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Lansoprazole	Lansoprazole	17	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	15	suppressed
Estradiol	Estradiol	15	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Nystatin	Nystatin	15	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	15	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	13	suppressed
Risperidone	Risperidone	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Colchicine	Colchicine	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Torsemide	Torsemide	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error